| Type | Valeur |
|---|---|
| cik | 0000829323 |
| ticker | INUV |
Achats discrétionnaires moins ventes en USD par fenêtre roulante. Hors compensation.
| Date | Type | Insider | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 01 mars 2026 | EXERCISE | Howe Richard K | 41 667 | 0.00 USD | |
| 01 mars 2026 | TAX_WITHHOLDING | Howe Richard K | 19 411 | 2.55 USD | |
| 01 mars 2026 | EXERCISE | Howe Richard K | 41 667 | 0.00 USD | deriv |
| 01 mars 2026 | TAX_WITHHOLDING | RUIZ WALLACE D | 5 034 | 2.55 USD | |
| 01 mars 2026 | EXERCISE | RUIZ WALLACE D | 10 000 | 0.00 USD | |
| 01 mars 2026 | EXERCISE | RUIZ WALLACE D | 10 000 | 0.00 USD | deriv |
| 01 févr. 2026 | GRANT_AWARD | Buchner Robert C. | 75 000 | 0.00 USD | deriv |
| 08 janv. 2026 | EXERCISE | Bond Jonathan | 3 000 | 0.00 USD | |
| 08 janv. 2026 | EXERCISE | Bond Jonathan | 3 000 | 0.00 USD | deriv |
| 08 janv. 2026 | EXERCISE | Lee Kenneth Ewell | 3 000 | 0.00 USD | |
| 08 janv. 2026 | EXERCISE | Lee Kenneth Ewell | 3 000 | 0.00 USD | deriv |
| 08 janv. 2026 | EXERCISE | Buchner Robert C. | 3 000 | 0.00 USD | |
| 08 janv. 2026 | EXERCISE | Buchner Robert C. | 3 000 | 0.00 USD | deriv |
| 08 janv. 2026 | EXERCISE | Cameron Gordon J | 3 000 | 0.00 USD | |
| 08 janv. 2026 | EXERCISE | Cameron Gordon J | 3 000 | 0.00 USD | deriv |
| 02 janv. 2026 | GRANT_AWARD | Lee Kenneth Ewell | 3 000 | 0.00 USD | deriv |
| 02 janv. 2026 | GRANT_AWARD | Cameron Gordon J | 3 000 | 0.00 USD | deriv |
| 02 janv. 2026 | GRANT_AWARD | Bond Jonathan | 3 000 | 0.00 USD | deriv |
| 11 déc. 2025 | EXERCISE | Howe Richard K | 46 002 | 0.00 USD | |
| 11 déc. 2025 | TAX_WITHHOLDING | Howe Richard K | 25 873 | 3.01 USD | |
| 11 déc. 2025 | EXERCISE | Howe Richard K | 46 002 | 0.00 USD | deriv |
| 11 déc. 2025 | EXERCISE | RUIZ WALLACE D | 14 100 | 0.00 USD | |
| 11 déc. 2025 | TAX_WITHHOLDING | RUIZ WALLACE D | 6 999 | 3.01 USD | |
| 11 déc. 2025 | EXERCISE | RUIZ WALLACE D | 14 100 | 0.00 USD | deriv |
| 30 sept. 2025 | GRANT_AWARD | Buchner Robert C. | 125 000 | 0.00 USD | deriv |